The study assessing molecular characteristics of lung adenocarcinomas, which harbor EGFR, KRAS mutations or ALK rearrangements as well as triple negative adenocarcinomas, dominated the top 10 alignment outcomes [59]. The gene discussed is EGFR; the disease is adenocarcinoma.